• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子数据显示,肺癌亚型之间存在保守的 DNA 位置区分和免疫基因的调控。

Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes.

机构信息

Erasmus University Medical Center, Departments of Pulmonary Diseases, Internal Medicine and Pathology, Bioinformatic Unit, Dr. Molewaterplein 40, 3015 GD, the Netherlands.

University of Groningen and University Medical Center Groningen, Departments of Pulmonary Diseases and Pathology and Medical Biology, Hanzeplein 1, 9713 GZ, Groningen, the Netherlands.

出版信息

Lung Cancer. 2020 Aug;146:341-349. doi: 10.1016/j.lungcan.2020.06.008. Epub 2020 Jun 20.

DOI:10.1016/j.lungcan.2020.06.008
PMID:32645666
Abstract

INTRODUCTION

Non-small-cell lung cancer exhibits a range of transcriptional and epigenetic patterns that not only define distinct phenotypes, but may also govern immune related genes, which have a major impact on survival.

METHODS

We used open-source RNA expression and DNA methylation data of the Cancer Genome Atlas with matched non-cancerous tissue to evaluate whether these pretreatment molecular patterns also influenced genes related to the immune system and overall survival.

RESULTS

The distinction between lung adenocarcinoma and squamous cell carcinoma are determined by 1083 conserved methylation loci and RNA expression of 203 genes which differ for >80 % of patients between the two subtypes. Using the RNA expression profiles of 6 genes, more than 95 % of patients could be correctly classified as having either adeno or squamous cell lung cancer. Comparing tumor tissue with matched normal tissue, no differences in RNA expression were found for costimulatory and co-inhibitory genes, nor genes involved in cytokine release. However, genes involved in antigen presentation had a lower expression and a wider distribution in tumor tissue.

DISCUSSION

Only a small number of genes, influenced by DNA methylation, determine the lung cancer subtype. The antigen presentation of cancer cells is dysfunctional, while other T cell immune functions appear to remain intact.

摘要

简介

非小细胞肺癌表现出一系列转录和表观遗传模式,这些模式不仅定义了不同的表型,而且可能还控制着与免疫相关的基因,这些基因对生存有重大影响。

方法

我们使用癌症基因组图谱的开源 RNA 表达和 DNA 甲基化数据,并结合配对的非癌组织,评估这些预处理分子模式是否也会影响与免疫系统和整体生存相关的基因。

结果

肺腺癌和鳞状细胞癌的区别由 1083 个保守的甲基化位点和 203 个基因的 RNA 表达决定,这两个亚型之间超过 80%的患者存在差异。使用 6 个基因的 RNA 表达谱,超过 95%的患者可以正确分类为患有腺癌或鳞状细胞肺癌。与配对的正常组织相比,在共刺激和共抑制基因以及细胞因子释放相关基因中没有发现 RNA 表达的差异。然而,参与抗原呈递的基因在肿瘤组织中的表达较低且分布较广。

讨论

只有少数受 DNA 甲基化影响的基因决定了肺癌的亚型。癌细胞的抗原呈递功能失调,而其他 T 细胞免疫功能似乎保持完整。

相似文献

1
Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes.分子数据显示,肺癌亚型之间存在保守的 DNA 位置区分和免疫基因的调控。
Lung Cancer. 2020 Aug;146:341-349. doi: 10.1016/j.lungcan.2020.06.008. Epub 2020 Jun 20.
2
Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.早期肺腺癌特异性诊断性DNA甲基化生物标志物的鉴定。
Cancer Genet. 2020 Aug;246-247:1-11. doi: 10.1016/j.cancergen.2020.08.002. Epub 2020 Aug 7.
3
Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.表观遗传学失活的假定肿瘤抑制因子 SFRP3 与肺腺癌患者的不良预后相关。
Epigenetics. 2018;13(3):214-227. doi: 10.1080/15592294.2016.1229730. Epub 2018 Apr 18.
4
Multiplatform-based molecular subtypes of non-small-cell lung cancer.基于多平台的非小细胞肺癌分子亚型
Oncogene. 2017 Mar;36(10):1384-1393. doi: 10.1038/onc.2016.303. Epub 2016 Oct 24.
5
Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.ITIH5在肺腺癌中的低表达与患者的不良预后相关。
Epigenetics. 2015;10(10):903-12. doi: 10.1080/15592294.2015.1078049. Epub 2015 Aug 7.
6
Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.探索并比较肺腺癌和肺鳞癌之间的基因表达和甲基化差异。
J Cell Physiol. 2019 Apr;234(4):4454-4459. doi: 10.1002/jcp.27240. Epub 2018 Oct 14.
7
Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.对非小细胞肺癌患者的 DNA 拷贝数和甲基化进行全基因组组合分析,以破译生物标志物。
Cancer Lett. 2011 Dec 1;311(1):29-37. doi: 10.1016/j.canlet.2011.06.021. Epub 2011 Jun 24.
8
Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC.整合 CAGE 和 DNA 甲基化分析鉴定非小细胞肺癌中受表观遗传调控的基因。
Mol Cancer Res. 2017 Oct;15(10):1354-1365. doi: 10.1158/1541-7786.MCR-17-0191. Epub 2017 Jul 11.
9
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.肺腺癌和肺鳞癌基因表达亚型在肿瘤免疫格局上表现出显著差异。
J Thorac Oncol. 2017 Jun;12(6):943-953. doi: 10.1016/j.jtho.2017.03.010. Epub 2017 Mar 21.
10
Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.全基因组 DNA 甲基化分析鉴定非小细胞肺癌中的新型甲基化基因。
J Thorac Oncol. 2013 May;8(5):562-73. doi: 10.1097/JTO.0b013e3182863ed2.

引用本文的文献

1
Xprediction: Explainable EGFR-TKIs response prediction based on drug sensitivity specific gene networks.Xprediction:基于药物敏感性特异基因网络的可解释 EGFR-TKIs 响应预测。
PLoS One. 2022 May 18;17(5):e0261630. doi: 10.1371/journal.pone.0261630. eCollection 2022.
2
Integrative Analysis of Multi-Omics Identified the Prognostic Biomarkers in Acute Myelogenous Leukemia.多组学综合分析确定急性髓系白血病的预后生物标志物
Front Oncol. 2020 Dec 10;10:591937. doi: 10.3389/fonc.2020.591937. eCollection 2020.